BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Sean McCarthy to be a panelist at CED's Business Development Partnering Forum at the NC Biotech Center in Research Triangle Park, NC.
News | 12. 10. 2007
